1. Home
  2. AKR vs IBRX Comparison

AKR vs IBRX Comparison

Compare AKR & IBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Acadia Realty Trust

AKR

Acadia Realty Trust

HOLD

Current Price

$21.09

Market Cap

2.7B

Sector

Real Estate

ML Signal

HOLD

Logo ImmunityBio Inc.

IBRX

ImmunityBio Inc.

HOLD

Current Price

$5.53

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AKR
IBRX
Founded
1993
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.6B
IPO Year
1993
N/A

Fundamental Metrics

Financial Performance
Metric
AKR
IBRX
Price
$21.09
$5.53
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
4
Target Price
$22.00
$11.50
AVG Volume (30 Days)
1.5M
18.5M
Earning Date
02-10-2026
03-02-2026
Dividend Yield
3.82%
N/A
EPS Growth
18.54
N/A
EPS
0.12
N/A
Revenue
$389,489,000.00
$82,555,000.00
Revenue This Year
N/A
$667.58
Revenue Next Year
$16.18
$92.92
P/E Ratio
$169.77
N/A
Revenue Growth
6.01
1025.95
52 Week Low
$16.98
$1.83
52 Week High
$24.95
$4.27

Technical Indicators

Market Signals
Indicator
AKR
IBRX
Relative Strength Index (RSI) 59.97 92.86
Support Level $20.67 $1.95
Resistance Level $21.20 $2.29
Average True Range (ATR) 0.45 0.28
MACD 0.00 0.30
Stochastic Oscillator 84.80 98.48

Price Performance

Historical Comparison
AKR
IBRX

About AKR Acadia Realty Trust

Acadia Realty Trust is a real estate investment trust that specializes in the operation, management, leasing, renovation, and acquisition of shopping centers and mixed-use properties with retail components. The company operates through three segments: Core Portfolio segment consists primarily of high-quality retail properties located primarily in high-barrier-to-entry, densely-populated metropolitan areas with a long-term investment horizon; Investment Management segment holds primarily retail real estate in which the company co-invests with high-quality institutional investors; and Structured Financing segment consists of earnings and expenses related to notes and mortgages receivable Fees earned by the company as the general partner or managing member through Investment Management.

About IBRX ImmunityBio Inc.

ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its platforms for the development of biologic product candidates include (i) antibody-cytokine fusion proteins, (ii) DNA, RNA, and recombinant protein vaccines, and (iii) cell therapies. Its focus includes bladder, lung, and colorectal cancers and GBM and its product candidate Anktiva is an IL-15 superagonist antibody-cytokine fusion protein. It has two geographical segments: the United States and Europe. Key revenue is generated from the United States.

Share on Social Networks: